Need help finding what you are looking for?
Contact Us
PUBLISHER: DelveInsight | PRODUCT CODE: 2082655
PUBLISHER: DelveInsight | PRODUCT CODE: 2082655
Iron Deficiency Anemia - Epidemiology Forecast - 2036
PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Iron Deficiency Anemia (IDA) Insights and Trends
- According to DelveInsight's analysis, the total prevalent cases of IDA were ~31,370,000 in the 7MM (the United States, the EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan) in 2025.
- IDA is more prevalent in Asian countries such as Japan due to dietary patterns with lower iron intake, higher prevalence of gastrointestinal disorders affecting iron absorption, aging populations, and increased prevalence of chronic diseases that contribute to iron deficiency.
- Females face a higher lifetime risk of developing IDA and experience a greater disease burden compared to males. This disparity is largely attributed to physiological and reproductive factors, as women are more likely to experience menstrual blood loss, pregnancy-related iron demands, and nutritional deficiencies, all of which increase the risk of IDA.
- Population growth, dietary insufficiencies, menstrual blood loss in females, and increased prevalence of chronic diseases are expected to sustain the global IDA burden over the next decade. Strengthening nutritional programs, improving early diagnosis, and expanding access to effective iron therapies will remain key determinants of future trends.
Iron Deficiency Anemia (IDA) Epidemiology Forecast
- 2025 Prevalent Cases of IDA: ~31,370,000
- IDA Growth Rate (2026-2036): ~0.3% CAGR
DelveInsight's 'Iron Deficiency Anemia (IDA) - Epidemiology Forecast - 2036' report delivers an in-depth understanding of the IDA, historical and forecasted epidemiology in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Iron Deficiency Anemia (IDA) Understanding and Diagnosis Algorithm
IDA Overview
Iron Deficiency Anemia (IDA) is the most common form of anemia, occurring when low iron levels reduce hemoglobin production and impair oxygen transport in the body. It can range from mild to severe, with symptoms such as fatigue, weakness, and shortness of breath, especially in advanced stages. IDA is mainly caused by poor iron intake, blood loss, or reduced absorption. Diagnosis is based on blood tests, and treatment typically involves oral or intravenous iron supplementation, with transfusion required in severe cases.
IDA Diagnosis
Iron Deficiency Anemia (IDA) is diagnosed through physical examination and blood tests, often detected during routine checkups. A complete blood count (CBC) is the primary test, showing low hemoglobin, hematocrit, and smaller red blood cells. Additional tests such as serum iron, ferritin, and total iron-binding capacity (TIBC) confirm iron deficiency. If needed, further investigations like stool tests or endoscopy are done to identify underlying causes such as internal bleeding.
Iron Deficiency Anemia (IDA) Epidemiology
Key Findings from IDA Epidemiological Analysis and Forecast
- According to DelveInsight's estimates, the total prevalent cases of IDA in the 7MM were approximately 31,370,000 in 2025.
- Among the EU4, Germany accounted for the highest number of prevalent cases of IDA, followed by Spain, whereas France accounted for the lowest number of cases in 2025.
- The observed female predominance and earlier onset of IDA highlight the importance of sex-specific screening and early intervention strategies, particularly in recognizing susceptibility patterns and addressing disease at onset to prevent long-term complications.
- The prevalence of anemia was 9.3% in the US population aged 2 years and older. Males had a lower prevalence of anemia than females.
Scope of the Report:
- The report covers a segment of an executive summary, a descriptive overview of IDA, explaining its causes, signs and symptoms, and pathogenesis.
- Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.
Report Insights
Iron Deficiency Anemia (IDA) Patient Population Forecast
Report Key Strengths
- Epidemiology-based (epi-based) Bottom-up Forecasting
- 11-year Forecast
- Patient Burden Trends (by geography)
FAQs:
- What are the disease risks, burdens, and unmet needs of IDA? What will be the growth opportunities across the 7MM concerning the patient population with IDA?
- What is the historical and forecasted IDApatient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?
Reasons to Buy:
- Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
- To understand key opinion leaders' perspectives around the diagnostic challenges to overcome barriers in the future.
- Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.
Product Code: DIEI0125
Table of Contents
1. Key Insights
2. Report Introduction
3. Executive Summary of IDA
4. Epidemiology Forecast Methodology of IDA
5. IDA Epidemiology Overview at a Glance
- 5.1. Patient Share (%) Distribution by Country in 2025 in the 7MM
- 5.2. Patient Share (%) Distribution by Country in 2036 in the 7MM
6. Disease Background and Overview of IDA
- 6.1. Introduction
- 6.2. Types
- 6.3. Signs and Symptoms
- 6.4. Causes
- 6.5. Risk Factors Associated With IDA
- 6.6. Pathophysiology
- 6.7. Diagnosis
- 6.7.1. Differential Diagnosis
- 6.7.2. Diagnosis Algorithm
- 6.5.3. Diagnosis Guidelines
7. Epidemiology and Patient Population of IDA
- 7.1. Key Findings
- 7.2. Assumptions and Rationale
- 7.3. Total Prevalent Cases of IDA in the 7MM
- 7.4. The United States
- 7.4.1. Total Prevalent Cases of Iron Deficiency Anemia (IDA) in US
- 7.4.2. Total Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in US
- 7.4.3. Gender-Specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in US
- 7.4.4. Pathology-Specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in US
- 7.4.5. Severity-specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in US
- 7.4.6. Total treated Cases of Iron Deficiency Anemia (IDA) in US
- 7.5. EU4 and the UK
- 7.5.1. Total Prevalent Cases of Iron Deficiency Anemia (IDA) in EU4 and the UK
- 7.5.2. Total Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in EU4 and the UK
- 7.5.3. Gender-Specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in EU4 and the UK
- 7.5.4. Pathology-Specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in EU4 and the UK
- 7.5.5. Severity-specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in EU4 and the UK
- 7.5.6. Total treated Cases of Iron Deficiency Anemia (IDA)
- 7.6. Japan
- 7.6.1. Total Prevalent Cases of Iron Deficiency Anemia (IDA) in Japan
- 7.6.2. Total Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in Japan
- 7.6.3. Gender-Specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in Japan
- 7.6.4. Pathology-Specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in Japan
- 7.6.5. Severity-specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in Japan
- 7.6.6. Total treated Cases of Iron Deficiency Anemia (IDA) in Japan
8. Appendix
- 8.1. Bibliography
- 8.2. Report Methodology
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
Product Code: DIEI0125
List of Tables
- Table 1: Summary of IDA: Market, Epidemiology, and Key Events (2022-2036)
- Table 2: Severity of Anemia in Different Age Groups, Sex, and Pregnancy Status by level of hemoglobin (g/dL)
- Table 3: Differential Diagnosis of IDA
- Table 4: The United States
- Table 5: Total Prevalent Cases of Iron Deficiency Anemia (IDA) in US
- Table 6: Total Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in US
- Table 7: Gender-Specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in US
- Table 8: Pathology-Specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in US
- Table 9: Severity-specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in US
- Table 10: Total treated Cases of Iron Deficiency Anemia (IDA) in US
- Table 11: EU4 and the UK
- Table 12: Total Prevalent Cases of Iron Deficiency Anemia (IDA) in EU4 and the UK
- Table 13: Total Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in EU4 and the UK
- Table 14: Gender-Specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in EU4 and the UK
- Table 15: Pathology-Specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in EU4 and the UK
- Table 16: Severity-specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in EU4 and the UK
- Table 17: Total treated Cases of Iron Deficiency Anemia (IDA)
- Table 18: Japan
- Table 19: Total Prevalent Cases of Iron Deficiency Anemia (IDA) in Japan
- Table 20: Total Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in Japan
- Table 21: Gender-Specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in Japan
- Table 22: Pathology-Specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in Japan
- Table 23: Severity-specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in Japan
- Table 24: Total treated Cases of Iron Deficiency Anemia (IDA) in Japan
List of Figures
- Figure 1: Classification of Anemia
- Figure 2: Signs and Symptoms of IDA
- Figure 3: Risk Factors of IDA
- Figure 4: Iron Circuit in the Human Body
- Figure 5: Differential Diagnosis of IDA
- Figure 6: Diagnostic Algorithm for IDA
- Figure 7: The United States
- Figure 8: Total Prevalent Cases of Iron Deficiency Anemia (IDA) in US
- Figure 9: Total Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in US
- Figure 10: Gender-Specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in US
- Figure 11: Pathology-Specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in US
- Figure 12: Severity-specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in US
- Figure 13: Total treated Cases of Iron Deficiency Anemia (IDA) in US
- Figure 14: EU4 and the UK
- Figure 15: Total Prevalent Cases of Iron Deficiency Anemia (IDA) in EU4 and the UK
- Figure 16: Total Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in EU4 and the UK
- Figure 17: Gender-Specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in EU4 and the UK
- Figure 18: Pathology-Specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in EU4 and the UK
- Figure 19: Severity-specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in EU4 and the UK
- Figure 20: Total treated Cases of Iron Deficiency Anemia (IDA)
- Figure 21: Japan
- Figure 22: Total Prevalent Cases of Iron Deficiency Anemia (IDA) in Japan
- Figure 23: Total Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in Japan
- Figure 24: Gender-Specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in Japan
- Figure 25: Pathology-Specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in Japan
- Figure 26: Severity-specific Diagnosed Prevalent Cases of Iron Deficiency Anemia (IDA) in Japan
- Figure 27: Total treated Cases of Iron Deficiency Anemia (IDA) in Japan
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.